COLUMN GROUP III GP, LP sold 62.4% of their position (4.40M shares) of TENAYA THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.04M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/12/2026ACC: 0001193125-26-049028
10% Owner
Since Jul 2021
-4.40M
Net shares
Net seller
$3.04M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
4.40M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−161.42K
Price / share
$0.82
Trade value
$131.74K
% of position
3.7%
2/10/2026
4.41M→4.25M
Common Stock
Indirect
Shares
−182.29K
Price / share
$0.82
Trade value
$148.77K
% of position
3.7%
2/10/2026
4.99M→4.80M
Common Stock
Indirect
Shares
−1.91M
Price / share
$0.68
Trade value
$1.30M
% of position
44.8%
2/11/2026
4.25M→2.35M
Common Stock
Indirect
Shares
−2.15M
Price / share
$0.68
Trade value
$1.46M
% of position
44.8%
2/11/2026
4.80M→2.65M
Total
Net shares
−4.40M
Net value
-$3.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/10/2026 | S · Sale | −161.42K | $0.82 | $131.74K | 3.7% | 4.41M | 4.25M |
| Common Stock Indirect | 2/10/2026 | S · Sale | −182.29K | $0.82 | $148.77K | 3.7% | 4.99M | 4.80M |
| Common Stock Indirect | 2/11/2026 | S · Sale | −1.91M | $0.68 | $1.30M | 44.8% | 4.25M | 2.35M |
| Common Stock Indirect | 2/11/2026 | S · Sale | −2.15M | $0.68 | $1.46M | 44.8% | 4.80M | 2.65M |
| Total | −4.40M | -$3.04M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned49.31M
Total
49.31M indirect49.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 49.31M | Indirect |
| Total | 49.31M | 49.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported